GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Total Equity

MYND Life Sciences (XCNQ:MYND) Total Equity : C$-5.35 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Total Equity?

MYND Life Sciences's total equity for the quarter that ended in Jan. 2024 was C$-5.35 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


MYND Life Sciences Total Equity Historical Data

The historical data trend for MYND Life Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Total Equity Chart

MYND Life Sciences Annual Data
Trend Oct21 Oct22 Oct23
Total Equity
-0.07 -3.53 -4.98

MYND Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.37 -4.99 -5.47 -4.98 -5.35

MYND Life Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

MYND Life Sciences's Total Equity for the fiscal year that ended in Oct. 2023 is calculated as

Total Equity=Total Assets(Q: Oct. 2023 )-Total Liabilities(Q: Oct. 2023 )
=0.798-5.775
=-4.98

MYND Life Sciences's Total Equity for the quarter that ended in Jan. 2024 is calculated as

Total Equity=Total Assets(Q: Jan. 2024 )-Total Liabilities(Q: Jan. 2024 )
=0.771-6.121
=-5.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MYND Life Sciences Total Equity Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


MYND Life Sciences (XCNQ:MYND) Business Description

Traded in Other Exchanges
Address
05-2248 Elgin Ave., Port Coquitlam, BC, CAN, V3C 2B2
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.

MYND Life Sciences (XCNQ:MYND) Headlines

From GuruFocus

Mynd.ai, Inc. Consummates Merger Transaction

By PRNewswire 12-13-2023